GlassScriptPhysician profile
Herbert H Lee
NPI 1740206689
$82,989.78
in general payments reported to CMS, 2019-2025
10 companies · $7,337 in 2025
The $7,337 reported for 2025 was more than what 92% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $6,233 · 2021: $8,021 · 2022: $8,315 · 2023: $11K · 2024: $23K · 2025: $7,337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Travel and Lodging: $3,238 · Food and Beverage: $2,774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35,120.00 |
| Travel and Lodging | $3,237.61 |
| Food and Beverage | $2,774.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $68,535.67 | 2019-2025 | Vemlidy |
| Phathom Pharmaceuticals, INC. | $14,122.53 | 2023-2025 | Voquezna |
| Alnylam Pharmaceuticals INC. | $146.18 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.97 | 2019-2025 | Eohilia |
| Abbvie INC. | $34.33 | 2022-2023 | |
| Capsovision, INC. | $32.01 | 2025 | Capsocam Plus |
| Madrigal Pharmaceuticals | $29.54 | 2025 | Rezdiffra |
| Covidien LP | $22.82 | 2019 | |
| Intercept Pharmaceuticals, INC. | $16.54 | 2020 | |
| Braintree Laboratories, INC. | $14.19 | 2025 | Sutab, Suflave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herbert Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.